Profusa, Inc.

Profusa, Inc. (PFSA) is a publicly traded healthcare and medical technology company focused on implantable, tissue-integrated biosensors for continuous real-time monitoring of biological signals. The company filed a Form 10-Q with the U.S. Securities and Exchange Commission on May 17, 2023, under accession number 0001213900-23-040837, reflecting its status as a reporting public company with quarterly disclosure obligations. Profusa operates in the digital health and life sciences sector, developing optical biosensor platforms designed to detect physiological parameters continuously and non-invasively. For full filing history, SPAC transaction details, sponsor information, and ongoing coverage of Profusa and hundreds of other deals, sign up for complete data access on SpacDesk.